SEC Form 4 · accession 0001144204-18-033542
DarioHealth Corp. · DRIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erez Raphael
Officer — Chief Executive Officer · Director
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001533998
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2018 | A | 706,294 | $0.00 | A | 1,217,133 | D | |
| Common StockF2 | holding | — | — | — | 757,509 | I | By Dicilyon Consulting and Investment Ltd. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Of the amount shown, 56,880 shares were awarded in lieu of a cash bonus compensation for the fiscal year of 2017 in the amount of $98,345.06.
- F2The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.